Moderna Inc
NASDAQ:MRNA 2:38:17 PM EDT
Products
Canada Exercises Increased Option For Total Of 40 Million Doses Of mRNA Vaccine Candidate Against COVID-19
Published: 12/07/2020 14:37 GMT
Moderna Inc (MRNA) - Canada Exercises Increased Option for Total of 40 Million Doses of Mrna Vaccine Candidate Against Covid-19 (mrna-1273).
Moderna Inc - Canadian Government Increased Confirmed Order Commitment by 20 Million Doses of Moderna's Vaccine Candidate Against Covid-19, Mrna-1273.
Moderna - Canadian Vaccine Supply to Be Sourced From European Production Capacity With Manufacturing Partners Lonza & Rovi for Fill-finish Services.
Moderna Inc - Moderna Could Ship Its Covid-19 Vaccine As Soon As December If Regulatory Approval is Granted This December.
Moderna Inc - Canadian Government Increased Confirmed Order Commitment by 20 Million Doses of Moderna's Vaccine Candidate Against Covid-19, Mrna-1273.
Moderna - Canadian Vaccine Supply to Be Sourced From European Production Capacity With Manufacturing Partners Lonza & Rovi for Fill-finish Services.
Moderna Inc - Moderna Could Ship Its Covid-19 Vaccine As Soon As December If Regulatory Approval is Granted This December.